izpis_h1_title_alt

Synthesis of 3-amino-4-substituted monocyclic ß-lactams—important structural motifs in medicinal chemistry
ID Grabrijan, Katarina (Author), ID Strašek Benedik, Nika (Author), ID Gobec, Stanislav (Author)

.pdfPDF - Presentation file, Download (3,51 MB)
MD5: B8E754148E25936B066BFC1AC7DD6BE7
URLURL - Source URL, Visit https://www.mdpi.com/1422-0067/23/1/360 This link opens in a new window

Abstract
Monocyclic ß-lactams (azetidin-2-ones) exhibit a wide range of biological activities, the most important of which are antibacterial, anticancer, and cholesterol absorption inhibitory activities. The synthesis of decorated monocyclic ß-lactams is challenging because their ring is highly constrained and consequently reactive, which is also an important determinant of their biological activity. We present the optimized synthesis of orthogonally protected 3-amino-4-substituted monocyclic ß-lactams. Among several possible synthetic approaches, Staudinger cycloaddition proved to be the most promising method for initial ring formation, yielding monocyclic ß-lactams with different substituents at the C-4 position, a phthalimido-protected 3-amino group, and a (dimethoxy)benzyl protected ring nitrogen. Challenging deprotection methods were then investigated. Oxidative cleavage with cerium ammonium nitrate and ammonia-free Birch reduction was found to be most effective for selective removal of ring nitrogen protection. Hydrazine hydrate was used for deprotection of the phthalimido group, and the procedure had to be modified by the addition of HCl in the case of aromatic substituents at the C-4 position. The presented methods and the synthesized 3-amino-4-substituted monocyclic ß-lactam derivatives are an important step toward new ß-lactams with potential pharmacological activities.

Language:English
Keywords:monocyclic ß-lactam, Staudinger [2+2] cyclocondensation, cerium ammonium nitrate, hydrazine hydrate, 3-amino-4-substituted azetidin-2-one, inhibitory activities
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2022
Number of pages:26 str.
Numbering:Vol. 23, iss. 1, art. 360
PID:20.500.12556/RUL-136778 This link opens in a new window
UDC:615.4:54
ISSN on article:1422-0067
DOI:10.3390/ijms23010360 This link opens in a new window
COBISS.SI-ID:92152323 This link opens in a new window
Publication date in RUL:20.05.2022
Views:635
Downloads:120
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:International journal of molecular sciences
Shortened title:Int. j. mol. sci.
Publisher:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:01.01.2022

Secondary language

Language:Slovenian
Keywords:monociklični ß-laktam, Staudingerjeva [2+2] ciklokondenzacija, cerijev amonijev nitrat, hidrazin hidrat, 3-amino-4-substituiran azetidin-2-on, inhibitorna aktivnost, farmacevtska kemija

Projects

Funder:ARRS - Slovenian Research Agency
Funding programme:Young researchers

Funder:ARRS - Slovenian Research Agency
Project number:P1-0208
Name:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back